[go: up one dir, main page]

MX2014012799A - Tabletas recubiertas y la produccion de las mismas. - Google Patents

Tabletas recubiertas y la produccion de las mismas.

Info

Publication number
MX2014012799A
MX2014012799A MX2014012799A MX2014012799A MX2014012799A MX 2014012799 A MX2014012799 A MX 2014012799A MX 2014012799 A MX2014012799 A MX 2014012799A MX 2014012799 A MX2014012799 A MX 2014012799A MX 2014012799 A MX2014012799 A MX 2014012799A
Authority
MX
Mexico
Prior art keywords
coating
production
tablets
formulations
hardness
Prior art date
Application number
MX2014012799A
Other languages
English (en)
Other versions
MX369549B (es
Inventor
Roberto Ognibene
Sandra Erika Bernhardt
Melanie Mechthild Breidung
Dieter Lubda
Hans-Leonhard Ohrem
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48045412&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2014012799(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of MX2014012799A publication Critical patent/MX2014012799A/es
Publication of MX369549B publication Critical patent/MX369549B/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/284Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/375Ascorbic acid, i.e. vitamin C; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/284Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846Poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893Tablet coating processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención proporciona una formulación farmacéutica que se desintegra rápidamente en la forma de una tableta recubierta que tiene una resistencia mecánica o dureza incrementada. La invención se refiere adicionalmente a un proceso para la producción de la tableta recubierta y el uso de esas formulaciones.
MX2014012799A 2012-04-27 2013-04-02 Un proceso para la fabricación de núcleos de tabletas duros con recubrimiento. MX369549B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12002988 2012-04-27
EP12006370 2012-09-11
PCT/EP2013/000971 WO2013159861A1 (de) 2012-04-27 2013-04-02 Tabletten mit überzug und deren herstellung

Publications (2)

Publication Number Publication Date
MX2014012799A true MX2014012799A (es) 2015-01-22
MX369549B MX369549B (es) 2019-11-12

Family

ID=48045412

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014012799A MX369549B (es) 2012-04-27 2013-04-02 Un proceso para la fabricación de núcleos de tabletas duros con recubrimiento.

Country Status (13)

Country Link
US (1) US20150104512A1 (es)
EP (1) EP2844234B1 (es)
JP (2) JP6363993B2 (es)
KR (1) KR102092002B1 (es)
CN (1) CN104244931A (es)
BR (1) BR112014026439B1 (es)
CA (1) CA2871703C (es)
CL (1) CL2014002896A1 (es)
ES (1) ES2784134T3 (es)
IL (1) IL234998B (es)
MX (1) MX369549B (es)
TW (2) TW201811316A (es)
WO (1) WO2013159861A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3288556A4 (en) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
MY191729A (en) * 2015-10-16 2022-07-13 Novex Science Pte Ltd Stable composition of vitamin c and zinc tablet
JP6738477B2 (ja) * 2016-03-16 2020-08-12 ゴールデン オメガ ノルウェー アーエス ω−3脂肪酸誘導体を含む粉末及び錠剤、ならびにその製造方法
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
JP2018184375A (ja) * 2017-04-27 2018-11-22 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ダビガトランエテキシラート又は医薬的に許容されるその塩を含む錠剤及びその製造方法
US11826473B2 (en) 2018-01-11 2023-11-28 Sawai Pharmaceutical Co., Ltd. Orally disintegrating tablet coated with film
JP7750663B2 (ja) * 2021-03-19 2025-10-07 エスエス製薬株式会社 被覆固形医薬製剤
CN118340736B (zh) * 2024-04-23 2024-10-18 海南恒诚三叶制药有限公司 头孢泊肟酯片及其制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100346832C (zh) * 2002-02-07 2007-11-07 法玛西雅公司 经粘膜递送的药物剂型
JP2008507587A (ja) * 2004-07-26 2008-03-13 テバ ファーマシューティカル インダストリーズ リミティド 腸溶性被覆されたコアー錠剤を有する投与形
BRPI0513598A (pt) * 2004-07-26 2008-05-13 Teva Pharma formas de dosagem em comprimidos revestidos de liberação entérica
JP5535616B2 (ja) * 2006-03-31 2014-07-02 ルビコン リサーチ プライベート リミテッド 口腔内崩壊錠剤のための直接圧縮性複合材
EP2066307B1 (en) 2006-09-15 2012-07-04 Capsugel Belgium NV Rapidly disintegrating dosage form
KR101442862B1 (ko) * 2006-12-07 2014-09-22 다이이찌 산쿄 가부시키가이샤 만니톨 또는 유당을 함유하는 고형 제제
EA201000545A1 (ru) * 2007-10-12 2010-10-29 Астразенека Аб Композиция зиботентана, содержащая маннит и/или микрокристаллическую целлюлозу
WO2009135646A2 (en) * 2008-05-05 2009-11-12 Farmaprojects, Sa Stable pharmaceutical compositions and their processes for preparation suitable for industrial scale
EP2299982B1 (de) * 2008-06-20 2018-04-04 Merck Patent GmbH Direkt verpressbare und schnell zerfallende tablettenmatirx
HRP20240365T1 (hr) * 2009-02-13 2024-06-07 Boehringer Ingelheim International Gmbh Farmaceutski pripravak koji sadrži derivate glukopiranozil difenilmetana, njegov farmaceutski oblik za doziranje, postupak za njihovu proizvodnju i njihove uporabe za poboljšanu regulaciju glikemije kod pacijenta
TWI455733B (zh) * 2009-03-30 2014-10-11 Toray Industries 口腔內崩壞性被覆錠劑
EP2506835B1 (en) 2009-11-30 2019-06-12 Adare Pharmaceuticals, Inc. Compressible-coated pharmaceutical compositions and tablets and methods of manufacture
TR201907882T4 (tr) * 2012-02-22 2019-06-21 Fujifilm Toyama Chemical Co Ltd 1-(3-(2-(1-Benzotiofen-5-il)etoksi)propil)azetidin-3-olü veya onun tuzunu içeren katı farmasötik bileşim

Also Published As

Publication number Publication date
JP6363993B2 (ja) 2018-07-25
IL234998B (en) 2019-07-31
BR112014026439B1 (pt) 2022-05-31
JP2015514786A (ja) 2015-05-21
TWI697341B (zh) 2020-07-01
TW201410268A (zh) 2014-03-16
CA2871703C (en) 2021-03-30
JP2017193585A (ja) 2017-10-26
EP2844234B1 (de) 2020-01-08
CA2871703A1 (en) 2013-10-31
TW201811316A (zh) 2018-04-01
EP2844234A1 (de) 2015-03-11
KR102092002B1 (ko) 2020-03-23
BR112014026439A2 (pt) 2017-06-27
KR20150003891A (ko) 2015-01-09
CL2014002896A1 (es) 2014-12-19
IL234998A0 (en) 2014-12-31
US20150104512A1 (en) 2015-04-16
ES2784134T3 (es) 2020-09-22
WO2013159861A1 (de) 2013-10-31
MX369549B (es) 2019-11-12
CN104244931A (zh) 2014-12-24

Similar Documents

Publication Publication Date Title
MX369549B (es) Un proceso para la fabricación de núcleos de tabletas duros con recubrimiento.
IL269054A (en) A pharmaceutical preparation containing tesimaltone for use in the treatment of 24-NON
PH12019501970A1 (en) Pharmaceutical compositions for combination therapy
CA141113S (en) Dispenser for pharmaceutical powder formulations
IL222268A (en) Preserved pyrollo-pyridines, containing pharmaceutical preparations, combined preparations containing them and their use in the preparation of medicines
IL231536A (en) Indazole-3-carboxamides, pharmaceuticals containing them and their use in the treatment of diseases
MX2013008850A (es) Composiciones y metodos para tratar enfermedades cardiovasculares.
AU346046S (en) Shower faceplate
GB201106750D0 (en) Novel compounds
AU338203S (en) Pill case
MX2014008774A (es) Sistemas de perfume.
CA143485S (en) Display box
PH12019501301A1 (en) Pharmaceutical compositions for combination therapy
AU345217S (en) Fire detector
GB2497453B (en) Pharmaceutical composition and methods of treating and preventing the diseases caused by HIV or associated with HIV
GB201222455D0 (en) Novel pharmaceutical formulations and their use in the treatment of periodontaldisease
MX2016006087A (es) Formulaciones de desintegracion rapida y metodos de uso.
MX2013001793A (es) Producto para la esfera gastrica superior.
IN2015DN02358A (es)
WO2011107866A3 (en) Silyl-derivatives of polysaccharides
MX2012002631A (es) Capsulas con aroma.
MX2015013755A (es) Formulacion farmaceutica para uso en el tratamiento y/o prevencion de restenosis.
WO2014027979A3 (en) Tablet formulations comprising tadalafil and dapoxetine
UA105944C2 (uk) Комбінація теоброміну з деконгестантом і її застосування для лікування кашлю
MX2014006201A (es) Formas de dosificaciones solidas de imatinib reconstituidas justo antes de usarse.

Legal Events

Date Code Title Description
FG Grant or registration